$855 Million is the total value of Rhenman & Partners Asset Management AB's 93 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 22.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Sell | United Health Group Inc | $30,512,000 | -3.1% | 123,400 | -2.4% | 3.57% | -0.8% |
| JAZZ | Buy | Jazz Pharmaceuticals Plc | $26,756,000 | +30.2% | 187,171 | +12.9% | 3.13% | +33.2% |
| VRTX | Buy | Vertex Pharmaceuticals Inc | $26,562,000 | +21.0% | 144,400 | +9.0% | 3.11% | +23.9% |
| ABMD | Buy | Abiomed Inc | $26,415,000 | +24.4% | 92,493 | +41.6% | 3.09% | +27.3% |
| CI | Cigna Corp Reg | $25,682,000 | -15.3% | 159,691 | 0.0% | 3.00% | -13.4% | |
| HZNP | Sell | Horizon Pharma Plc | $24,843,000 | +34.4% | 939,973 | -0.6% | 2.91% | +37.5% |
| NKTR | Buy | Nektar Therapeutics | $24,677,000 | +45.8% | 734,445 | +42.6% | 2.89% | +49.1% |
| LIVN | Buy | Livanova Plc | $23,398,000 | +112.1% | 240,600 | +99.5% | 2.74% | +117.0% |
| NVCR | Sell | NovoCure Ltd Reg | $21,900,000 | +20.0% | 454,647 | -16.6% | 2.56% | +22.8% |
| ANTM | Sell | Anthem Inc | $21,135,000 | +2.3% | 73,645 | -6.4% | 2.47% | +4.7% |
| ABT | Sell | Abbott Laboratories | $20,749,000 | +8.4% | 259,552 | -1.9% | 2.43% | +11.0% |
| BMRN | Buy | BioMarin Pharmaceutical Inc | $20,568,000 | +36.8% | 231,549 | +31.2% | 2.41% | +40.0% |
| HUM | Sell | Humana Inc | $20,482,000 | -13.2% | 77,000 | -6.6% | 2.40% | -11.2% |
| ESPR | Buy | Esperion Therapeutics Inc | $19,263,000 | +18.3% | 479,767 | +35.5% | 2.25% | +21.1% |
| CVS | Sell | CVS Health Corp | $19,084,000 | -28.8% | 353,868 | -13.5% | 2.23% | -27.1% |
| BDX | Sell | Becton Dickinson & Co | $18,730,000 | -27.7% | 75,000 | -34.8% | 2.19% | -26.0% |
| GKOS | Sell | Glaukos Corp | $18,462,000 | +36.6% | 235,579 | -2.1% | 2.16% | +39.7% |
| ALXN | Sell | Alexion Pharmaceuticals Inc | $18,447,000 | -17.8% | 136,466 | -40.8% | 2.16% | -15.9% |
| MGNX | Buy | Macrogenics Inc | $17,390,000 | +152.5% | 967,186 | +78.4% | 2.03% | +158.4% |
| NBIX | Sell | Neurocrine Biosciences Inc | $15,602,000 | +8.6% | 177,091 | -11.9% | 1.82% | +11.2% |
| MDT | Sell | Medtronic Plc Reg | $15,378,000 | -43.7% | 168,842 | -43.8% | 1.80% | -42.4% |
| ARRY | Sell | Array BioPharma Inc | $14,800,000 | +48.9% | 607,070 | -12.9% | 1.73% | +52.4% |
| BSX | Sell | Boston Scientific Corp | $14,120,000 | +5.7% | 367,908 | -2.6% | 1.65% | +8.2% |
| AGN | Sell | Allergan Plc | $12,972,000 | -1.6% | 88,600 | -10.1% | 1.52% | +0.7% |
| LLY | Sell | Eli Lilly & Co | $12,807,000 | -10.5% | 98,695 | -20.2% | 1.50% | -8.4% |
| AERI | Sell | Aerie Pharmaceuticals Inc | $12,350,000 | +22.2% | 260,000 | -7.1% | 1.44% | +25.1% |
| IMMU | Buy | Immunomedics Inc | $11,840,000 | +72.7% | 616,367 | +28.3% | 1.38% | +76.9% |
| MYOK | Buy | MyoKardia Inc Reg | $11,699,000 | +26.5% | 225,024 | +18.9% | 1.37% | +29.4% |
| ITCI | Buy | Intra-Cellular Therapies Inc | $11,569,000 | +53.9% | 949,833 | +43.9% | 1.35% | +57.5% |
| SGEN | Sell | Seattle Genetics Inc Reg | $11,030,000 | -19.6% | 150,598 | -37.8% | 1.29% | -17.8% |
| BMY | Sell | Bristol Myers Squibb Co | $10,973,000 | -42.9% | 230,000 | -37.8% | 1.28% | -41.7% |
| CNC | Buy | Centene Corp | $10,620,000 | -23.2% | 200,000 | +66.7% | 1.24% | -21.5% |
| ARNA | Sell | Arena Pharmaceuticals Inc Reg | $10,515,000 | -27.4% | 234,558 | -36.9% | 1.23% | -25.7% |
| FGEN | Sell | FibroGen Inc | $10,299,000 | -26.2% | 189,491 | -37.2% | 1.20% | -24.5% |
| EXEL | Sell | Exelixis Inc | $10,234,000 | -45.7% | 430,000 | -55.2% | 1.20% | -44.5% |
| XNCR | Buy | Xencor Inc | $10,124,000 | +28.1% | 325,965 | +49.2% | 1.18% | +31.1% |
| MRTX | Buy | Mirati Therapeutics Inc Reg | $9,316,000 | +158.3% | 127,093 | +49.5% | 1.09% | +164.6% |
| ABC | Buy | AmerisourceBergen Corp | $9,266,000 | +22.7% | 116,520 | +14.8% | 1.08% | +25.6% |
| WBA | Walgreens Boots Alliance Inc | $9,174,000 | -7.4% | 145,000 | 0.0% | 1.07% | -5.3% | |
| EXAS | New | Exact Sciences Corp Reg | $8,662,000 | – | 100,000 | +100.0% | 1.01% | – |
| BLUE | Sell | Bluebird Bio Inc | $8,653,000 | -26.0% | 55,000 | -53.3% | 1.01% | -24.3% |
| INCY | Sell | Incyte Corp Ltd | $8,601,000 | -49.2% | 100,000 | -62.5% | 1.01% | -48.1% |
| AGIO | Agios Pharmaceuticals Inc | $8,566,000 | +46.3% | 127,012 | 0.0% | 1.00% | +49.6% | |
| ALNY | Sell | Alnylam Pharmaceuticals Inc | $8,555,000 | +5.2% | 91,550 | -17.9% | 1.00% | +7.6% |
| IOVA | Sell | Iovance Biotherapeutics Inc Reg | $8,365,000 | -21.6% | 879,600 | -27.0% | 0.98% | -19.8% |
| SAGE | Sell | Sage Therapeutics Inc | $8,213,000 | -37.6% | 51,639 | -62.4% | 0.96% | -36.1% |
| TMO | Thermo Fisher Scientific Inc | $8,212,000 | +22.3% | 30,000 | 0.0% | 0.96% | +25.3% | |
| OMCL | Omnicell Inc | $8,114,000 | +32.0% | 100,375 | 0.0% | 0.95% | +35.0% | |
| SGMO | Sell | Sangamo Therapeutics Inc Reg | $8,051,000 | -36.5% | 843,957 | -23.6% | 0.94% | -35.0% |
| AMRN | Buy | Amarin Corp Plc spons ADR repr 1 Sharesponsored adr new | $7,698,000 | +465.6% | 370,800 | +270.8% | 0.90% | +476.9% |
| DPLO | Diplomat Pharmacy Inc Reg | $6,992,000 | -56.8% | 1,203,405 | 0.0% | 0.82% | -55.8% | |
| DERM | New | Dermira Inc Reg | $6,779,000 | – | 500,329 | +100.0% | 0.79% | – |
| REGN | Sell | Regeneron Pharmaceuticals Inc | $6,570,000 | +3.5% | 16,000 | -5.9% | 0.77% | +5.8% |
| CELG | Sell | Celgene Corp | $6,198,000 | -55.2% | 65,698 | -69.5% | 0.72% | -54.1% |
| CHRS | Buy | Coherus BioSciences Inc | $6,153,000 | +111.7% | 451,131 | +40.5% | 0.72% | +116.9% |
| RIGL | Rigel Pharmaceuticals Inc | $5,821,000 | +11.7% | 2,264,942 | 0.0% | 0.68% | +14.5% | |
| EW | Sell | Edwards Lifesciences Corp | $5,087,000 | -50.1% | 26,585 | -60.1% | 0.60% | -49.0% |
| VRAY | ViewRay Inc Reg | $4,907,000 | +21.7% | 664,023 | 0.0% | 0.57% | +24.5% | |
| ABBV | Sell | AbbVie Inc | $4,835,000 | -67.7% | 60,000 | -63.1% | 0.57% | -66.9% |
| ABEO | Abeona Therapeutics Inc Reg | $4,778,000 | +3.1% | 649,123 | 0.0% | 0.56% | +5.5% | |
| ALKS | Sell | Alkermes Plc | $4,393,000 | -14.6% | 120,399 | -31.0% | 0.51% | -12.6% |
| MDCO | Sell | Medicines Co | $3,634,000 | +40.6% | 130,000 | -3.7% | 0.42% | +44.1% |
| GTHX | Buy | G1 Therapeutics Inc Reg | $3,522,000 | +6.4% | 212,169 | +22.8% | 0.41% | +9.0% |
| MDGL | New | Madrigal Pharmaceuticals Inc Reg | $3,410,000 | – | 27,225 | +100.0% | 0.40% | – |
| RARX | New | Ra Pharmaceuticals Inc Reg | $3,360,000 | – | 150,000 | +100.0% | 0.39% | – |
| AIMT | New | Aimmune Therapeutics Inc Reg | $3,335,000 | – | 149,201 | +100.0% | 0.39% | – |
| XLRN | New | Acceleron Pharma Inc Reg | $3,260,000 | – | 70,000 | +100.0% | 0.38% | – |
| RVNC | Revance Therapeutics Inc | $3,045,000 | -21.7% | 193,181 | 0.0% | 0.36% | -20.0% | |
| NSTG | New | NanoString Technologies Inc Reg | $2,872,000 | – | 120,000 | +100.0% | 0.34% | – |
| QGEN | New | Qiagen NV Reg | $2,435,000 | – | 60,000 | +100.0% | 0.28% | – |
| DVAX | New | Dynavax Technologies Corp | $2,083,000 | – | 285,000 | +100.0% | 0.24% | – |
| FLXN | Sell | Flexion Therapeutics Inc | $1,463,000 | -74.5% | 117,265 | -76.9% | 0.17% | -73.9% |
| PIRS | Pieris Pharmaceuticals Inc Reg | $1,005,000 | +25.9% | 300,000 | 0.0% | 0.12% | +29.7% | |
| ACHN | Sell | Achillion Pharmaceuticals Inc | $822,000 | +28.4% | 277,800 | -31.0% | 0.10% | +31.5% |
| EPZM | New | Epizyme Inc Reg | $734,000 | – | 59,205 | +100.0% | 0.09% | – |
| ADVM | Adverum Biotechnologies Inc | $627,000 | +66.3% | 119,673 | 0.0% | 0.07% | +69.8% | |
| XOM | Exxon Mobil Corp | $494,000 | +18.5% | 6,111 | 0.0% | 0.06% | +20.8% | |
| SNSS | Sunesis Pharmaceuticals Inc Reg | $458,000 | +191.7% | 377,244 | 0.0% | 0.05% | +200.0% | |
| CVX | Chevron Corp | $460,000 | +13.3% | 3,733 | 0.0% | 0.05% | +17.4% | |
| DIS | The Walt Disney Co | $387,000 | +1.3% | 3,483 | 0.0% | 0.04% | +2.3% | |
| QCOM | Qualcomm Inc | $369,000 | 0.0% | 6,476 | 0.0% | 0.04% | +2.4% | |
| IBM | IBM Corp | $347,000 | +23.9% | 2,461 | 0.0% | 0.04% | +28.1% | |
| MSFT | Microsoft Corp | $340,000 | +16.0% | 2,887 | 0.0% | 0.04% | +21.2% | |
| BUD | Anheuser-Busch InBev SA ADR spons repr 1 Sharesponsored adr | $318,000 | +27.7% | 3,788 | 0.0% | 0.04% | +32.1% | |
| JHG | Janus Henderson Group Plc Reg | $295,000 | +20.4% | 11,828 | 0.0% | 0.04% | +25.0% | |
| F | Ford Motor Co | $285,000 | +14.9% | 32,405 | 0.0% | 0.03% | +17.9% | |
| JPM | JPMorgan Chase & Co | $278,000 | +3.7% | 2,747 | 0.0% | 0.03% | +6.5% | |
| WFC | Wells Fargo & Co | $283,000 | +4.8% | 5,858 | 0.0% | 0.03% | +6.5% | |
| HAL | Halliburton Co (Hg Co) | $270,000 | +10.2% | 9,221 | 0.0% | 0.03% | +14.3% | |
| SYMC | New | Symantec Corp | $224,000 | – | 9,734 | +100.0% | 0.03% | – |
| PFE | Pfizer Inc | $213,000 | -2.7% | 5,009 | 0.0% | 0.02% | 0.0% | |
| GOOGL | New | Alphabet Inc Acap stk cl a | $209,000 | – | 178 | +100.0% | 0.02% | – |
| CMRX | Sell | Chimerix Inc | $145,000 | -75.0% | 68,832 | -69.6% | 0.02% | -74.2% |
| ADMS | Exit | Adamas Pharmaceuticals Inc | $0 | – | -159,924 | -100.0% | -0.16% | – |
| LH | Exit | Laboratory Corp of America Hgs | $0 | – | -11,000 | -100.0% | -0.16% | – |
| LOXO | Exit | Loxo Oncology Inc | $0 | – | -10,000 | -100.0% | -0.16% | – |
| ONCE | Exit | Spark Therapeutics Inc | $0 | – | -88,302 | -100.0% | -0.40% | – |
| MD | Exit | Mednax Inc | $0 | – | -124,674 | -100.0% | -0.47% | – |
| PTLA | Exit | Portola Pharmaceuticals Inc | $0 | – | -241,964 | -100.0% | -0.54% | – |
| GILD | Exit | Gilead Sciences Inc | $0 | – | -188,200 | -100.0% | -1.35% | – |
| BIIB | Exit | Biogen Inc | $0 | – | -60,000 | -100.0% | -2.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-04-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.